| Market Cap | 78.65K 68.03K 63.53K 58.28K 110K 7.49M 111K 745K 293K 3.75M 295K 289K 12.4M | P/E 2021 |
-0.13x | P/E 2022 | -0.72x |
|---|---|---|---|---|---|
| Enterprise Value | 7.74M 6.7M 6.25M 5.74M 10.79M 737M 10.96M 73.38M 28.8M 369M 29.08M 28.44M 1.22B | EV / Sales 2021 |
8,440,812x | EV / Sales 2022 | 110,599,472x |
| Free-Float |
99.15% | Yield 2021 * |
-
| Yield 2022 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Mathew Watters
CEO | Chief Executive Officer | - | 2020-04-06 |
Anthony Laud
DFI | Director of Finance/CFO | - | 2021-09-16 |
| Director | Title | Age | Since |
|---|---|---|---|
Mathew Watters
BRD | Director/Board Member | - | 2020-03-26 |
Brigitte Simons
BRD | Director/Board Member | - | 2021-05-12 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | +41.94% | - | - | 2 | ||
| +0.14% | -3.97% | -9.18% | -6.40% | 13.42B | ||
| +0.85% | -4.86% | -31.19% | -56.13% | 5.09B | ||
| -0.84% | -2.23% | +4.50% | -1.89% | 5.05B | ||
| +4.49% | +0.59% | +6.32% | -29.15% | 4.21B | ||
| +0.84% | -2.90% | -6.91% | -8.87% | 3.69B | ||
| -4.39% | -3.50% | -2.12% | +4.52% | 3.54B | ||
| +1.48% | -2.48% | -2.48% | +17.75% | 3.48B | ||
| +3.37% | +1.21% | -11.98% | -18.33% | 2.49B | ||
| +0.23% | -3.30% | -3.72% | +46.80% | 1.86B | ||
| Average | +0.62% | -2.13% | -6.31% | -5.74% | 4.76B | |
| Weighted average by Cap. | +0.52% | -2.37% | -7.26% | -9.75% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 1.08 0.93 0.87 0.8 1.5 102.65 1.53 10.22 4.01 51.45 4.05 3.96 170.09 | 0.08 0.07 0.07 0.06 0.12 7.94 0.12 0.79 0.31 3.98 0.31 0.31 13.16 |
| Net income | -16.71M -14.46M -13.5M -12.39M -23.3M -1.59B -23.67M -158M -62.18M -797M -62.77M -61.39M -2.64B | -2.18M -1.89M -1.76M -1.62M -3.04M -207M -3.09M -20.66M -8.11M -104M -8.19M -8.01M -344M |
| Net Debt | 6.63M 5.74M 5.36M 4.92M 9.25M 631M 9.39M 62.87M 24.68M 316M 24.91M 24.37M 1.05B | 7.66M 6.63M 6.19M 5.68M 10.68M 729M 10.85M 72.64M 28.51M 366M 28.78M 28.15M 1.21B |
Employees
-
Sector
Pharmaceuticals
















